Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Herr
    Herr
  2. Vickers
    Vickers
  3. Russo
    Russo
  4. Eastham
    Eastham
  5. Jarnagin
    Jarnagin
  6. Reuter
    Reuter
  7. D'Angelica
    D'Angelica
  8. Kingham
    Kingham
  9. Ladanyi
    Ladanyi
  10. Scher
    Scher

Groups

  1. Surgery (2049)
  2. Department of Medicine (1334)
  3. Urology (1158)
  4. Solid Tumor Oncology Division (829)
  5. Population Sciences Research Program (816)
  6. Survivorship Research (716)
  7. Epidemiology and Biostatistics (685)
  8. Sloan Kettering Institute Faculty (612)
  9. Department of Pathology and Laboratory Medicine (586)
  10. GSK Faculty (582)
Search Within
Formats
  1. Journal Article (3901)
  2. Meeting Abstract (1049)
  3. Editorial (165)
  4. Review (132)
  5. Correspondence (113)
  6. Guidelines (79)
  7. Research Letter (29)
  8. Conference Paper (27)
  9. Book Section (5)
  10. Miscellaneous (3)
Groups
  1. Surgery (2049)
  2. Department of Medicine (1334)
  3. Urology (1158)
  4. Solid Tumor Oncology Division (829)
  5. Population Sciences Research Program (816)
  6. Survivorship Research (716)

More Groups

People
  1. Harry Herr (270)
  2. Andrew Vickers (223)
  3. Paul Russo (185)
  4. Peter Scardino (173)
  5. James Eastham (161)
  6. William Jarnagin (157)

More People

Years
  1. 2025 (96)
  2. 2024 (256)
  3. 2023 (234)
  4. 2022 (264)
  5. 2021 (233)
  6. 2020 (264)

More Years

Publications
  1. Journal of Urology (762)
  2. European Urology (570)
  3. Lancet Oncology (394)
  4. Urology (388)
  5. Journal of the American College of Surgeons (346)
  6. Journal of Molecular Diagnostics (272)

More Publications

Results (5503)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predictors of progression-free survival and local tumor control after percutaneous thermal ablation of oligometastatic breast cancer: Retrospective study
    Journal Article

    Ridouani, F.; Solomon, S. B.; Bryce, Y.; Bromberg, J. F.; Sofocleous, C. T.; Deipolyi, A. R.
    Journal of Vascular and Interventional Radiology (2020)

    Fulltext@MSK | Save
  • AHPBA Webinar about Covid-19: Lessons learned responding to a pandemic
    Editorial

    Cleary, S.; D'Angelica, M.; Demartines, N.; Doyle, M. B.; Kent, T.; Pawlik, T. M.
    HPB (2020)

    Fulltext@MSK | Save
  • Reply to Benjamin S. Simpson, Lina M. Carmona Echeverria, Joseph M. Norris, Hashim U. Ahmed, Caroline M. Moore, and Hayley C. Whitaker's letter to the editor re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of changes in magnetic resonance imaging or clinical stage in evaluation of disease progression for men with prostate cancer on active surveillance. Eur Urol 2020;77:501–7
    Correspondence

    Chesnut, G. T.; Vickers, A. J.; Ehdaie, B.
    European Urology (2020)

    Fulltext@MSK | Save
  • Routine use of magnetic resonance imaging for early detection of prostate cancer is not justified by the clinical trial evidence
    Editorial

    Vickers, A.; Carlsson, S. V.; Cooperberg, M.
    European Urology (2020)

    Fulltext@MSK | Save
  • Reply to Roderick C.N. van den Bergh, Olivier Rouvière, and Theodorus van der Kwast's letter to the editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine use of magnetic resonance imaging for early detection of prostate cancer is not justified by the clinical trial evidence. Eur Urol 2020;78:304–6. Prebiopsy MRI: Through the looking glass
    Correspondence

    Vickers, A.; Carlsson, S. V.; Cooperberg, M.
    European Urology (2020)

    Fulltext@MSK | Save
  • Reply to Jianhui Du, Yueguang Liu, and Weigang Yan's letter to the editor re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of changes in magnetic resonance imaging or clinical stage in evaluation of disease progression for men with prostate cancer on active surveillance. Eur Urol 2020;77:501–7
    Correspondence

    Chesnut, G. T.; Vertosick, E. A.; Ehdaie, B.
    European Urology (2020)

    Fulltext@MSK | Save
  • Standardized nomenclature and surveillance methodologies after focal therapy and partial gland ablation for localized prostate cancer: An international multidisciplinary consensus
    Journal Article

    Lebastchi, A. H.; George, A. K.; Polascik, T. J.; Coleman, J.; de la Rosette, J.; Turkbey, B.; Wood, B. J.; Gorin, M. A.; Sidana, A.; Ghai, S.; more...
    European Urology (2020)

    Fulltext@MSK | Save
  • The American Brachytherapy Society consensus statement for skin brachytherapy
    Guidelines

    Shah, C.; Ouhib, Z.; Kamrava, M.; Koyfman, S. A.; Campbell, S. R.; Bhatnagar, A.; Canavan, J.; Husain, Z.; Barker, C. A.; Cohen, G. N.; more...
    Brachytherapy (2020)

    Fulltext@MSK | Save
  • A combined FAK, c-MET, and MST1R three-protein panel risk-stratifies colorectal cancer patients
    Journal Article

    Yoon, J. Y.; Wang, J. Y.; Roehrl, M. H. A.
    Translational Oncology (2020)

    Fulltext@MSK | Save
  • Hereditary diffuse gastric cancer: Updated clinical practice guidelines
    Review

    Blair, V. R.; McLeod, M.; Carneiro, F.; Coit, D. G.; D'Addario, J. L.; van Dieren, J. M.; Harris, K. L.; Hoogerbrugge, N.; Oliveira, C.; van der Post, R. S.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save